GLP-1s ischaemic optic neuropathy NAION non-arteritic anterior ischaemic optic neuropathy TGA newsGP weekly poll Which MBS topic would you most like a dedicated session on as part of the RACGPs joint CPD activities with DoHDA?
The Schott call seemed to confirm one thing: the weakness was company-specific and, if anything, it confirmed that Stevanato is probably going to take the US market by storm as its two closest peers have slept at the wheel (more on this later)
Journal of Immunology, 187 (3), 1201-1206
bottom line: While the combination of topiramate and semaglutide is scientifically sound and often effective, it requires the watchful eye of a medical professional to manage the potential for overlapping side effects and ensure proper hydration
By the end of 2025, WEGOVY was available in 52 countries worldwide, nearly doubling its global footprint, with additional launches planned for 2026, subject to regulatory approvals